Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Revenue (2020 - 2026)

Trulieve Cannabis has reported Revenue over the past 6 years, most recently at $293.1 million for Q4 2025.

  • For Q4 2025, Revenue fell 2.66% year-over-year to $293.1 million; the TTM value through Dec 2025 reached $1.2 billion, changed 0.45%, while the annual FY2025 figure was $1.2 billion, 0.45% changed from the prior year.
  • Revenue for Q4 2025 was $293.1 million at Trulieve Cannabis, up from $288.2 million in the prior quarter.
  • Over five years, Revenue peaked at $317.7 million in Q1 2022 and troughed at $193.8 million in Q1 2021.
  • A 5-year average of $282.7 million and a median of $294.2 million in 2022 define the central range for Revenue.
  • Biggest five-year swings in Revenue: skyrocketed 101.78% in 2021 and later fell 10.24% in 2023.
  • Year by year, Revenue stood at $298.9 million in 2021, then dropped by 0.14% to $298.5 million in 2022, then fell by 3.85% to $287.0 million in 2023, then increased by 4.94% to $301.1 million in 2024, then fell by 2.66% to $293.1 million in 2025.
  • Business Quant data shows Revenue for TCNNF at $293.1 million in Q4 2025, $288.2 million in Q3 2025, and $302.1 million in Q2 2025.